Anxiety phenotype in mice that overexpress protein kinase A

Psychoneuroendocrinology

Volumn 37, Issue 6, 2012, Pages 836-843

  Keil, Margaret F ^a,b   Briassoulis, George ^a   Gokarn, Nirmal ^a   Nesterova, Maria ^a   Wu, T John ^b   Stratakis, Constantine A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Amygdala; Anxiety; Behavioral phenotype; Protein kinase a; Transgenic mouse model

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BASOLATERAL AMYGDALA; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL TEST; FEMALE; GENE; GENE MUTATION; GENOTYPE; HOT PLATE TEST; MALE; MARBLE BURY TEST; MAZE TEST; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PRKAR1A GENE; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

AFFECT; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT; DNA; EMOTIONS; GENOTYPE; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PAIN MEASUREMENT; PHENOTYPE; POLYMERASE CHAIN REACTION; STRESS, PSYCHOLOGICAL;

EID: 84859866360     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.09.016     Document Type: Article

References (58)

1. Adamec R.E., Blundell J., Collins A. Neural plasticity and stress induced changes in defense in the rat. Neurosci. Biobehav. Rev. 2001, 25:721-744.
2. Adamec R.E., Burton P., Shallow T., Budgell J. Unilateral block of NMDA receptors in the amygdala prevents predator stress-induced lasting increases in anxiety-like behavior and unconditioned startle-effective hemisphere depends on the behavior. Physiol. Behav. 1999, 65:739-751.
3. Adams M.R., Brandon E.P., Chartoff E.H., Idzerda R.L., Dorsa D.M., Mcknight G.S. Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:12157-12161.
4. Amieux P.S., Cummings D.E., Motamed K., Brandon E.P., Wailes L.A., Le K., Idzerda R.L., Mcknight G.S. Compensatory regulation of RIalpha protein levels in protein kinase A mutant mice. J. Biol. Chem. 1997, 272:3993-3998.
5. Ballou L.R., Botting R.M., Goorha S., Zhang J., Vane J.R. Nociception in cyclooxygenase isozyme-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:10272-10276.
6. Batista D.L., Weinberg F., Stergiopoulos S.G., Meoli E., Griffin K., Stratakis C.A. Year Behavior Modifications in Mice Expressing R1 Alpha Protein Kinase A Subunit Mutant 2005, Endocrine Society, San Diego, CA.
7. Brandon E.P., Idzerda R.L., Mcknight G.S. Knockouts. Targeting the mouse genome: a compendium of knockouts (Part I). Curr. Biol. 1995, 5:625-634.
8. Brandon E.P., Logue S.F., Adams M.R., Qi M., Sullivan S.P., Matsumoto A.M., Dorsa D.M., Wehner J.M., Mcknight G.S., Idzerda R.L. Defective motor behavior and neural gene expression in RIIbeta-protein kinase A mutant mice. J. Neurosci. 1998, 18:3639-3649.
9. Broekkamp C.L., Rijk H.W., Joly-Gelouin D., Lloyd K.L. Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice. Eur. J. Pharmacol. 1986, 126:223-229.
10. 2+ channel activity by cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:11067-11072.
11. Burton K.A., Treash-Osio B., Muller C.H., Dunphy E.L., Mcknight G.S. Deletion of type IIalpha regulatory subunit delocalizes protein kinase A in mouse sperm without affecting motility or fertilization. J. Biol. Chem. 1999, 274:24131-24136.
12. Carobrez A.P., Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci. Biobehav. Rev. 2005, 29:1193-1205.
13. Cole J.C., Burroughs G.J., Laverty C.R., Sheriff N.C., Sparham E.A., Rodgers R.J. Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha 2-adrenoceptor mediation. Psychopharmacology (Berl.) 1995, 118:425-436.
14. Cummings D.E., Brandon E.P., Planas J.V., Motamed K., Idzerda R.L., Mcknight G.S. Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A. Nature 1996, 382:622-626.
15. Davis K.D. The neural circuitry of pain as explored with functional MRI. Neurol. Res. 2000, 22:313-317.
16. Davis M. The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 1992, 15:353-375.
17. Espejo E.F. Effects of weekly or daily exposure to the elevated plus-maze in male mice. Behav. Brain Res. 1997, 87:233-238.
18. Espejo E.F. Selective dopamine depletion within the medial prefrontal cortex induces anxiogenic-like effects in rats placed on the elevated plus maze. Brain Res. 1997, 762:281-284.
19. Favilla C., Abel T., Kelly M.P. Chronic Galphas signaling in the striatum increases anxiety-related behaviors independent of developmental effects. J. Neurosci. 2008, 28:13952-13956.
20. Fu Y., Han J., Ishola T., Scerbo M., Adwanikar H., Ramsey C., Neugebauer V. PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior. Mol. Pain 2008, 4:26.
21. Griffin K.J., Kirschner L.S., Matyakhina L., Stergiopoulos S., Robinson-White A., Lenherr S., Weinberg F.D., Claflin E., Meoli E., Cho-Chung Y.S., Stratakis C.A. Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors. Cancer Res. 2004, 64:8811-8815.
22. Griffin K.J., Kirschner L.S., Matyakhina L., Stergiopoulos S., Robinson-White A., Weinberg F., Meoli E., Bornstein S.R., Stratakis C.A. A mouse model for Carney complex. Endocr. Res. 2004, 30:903-911.
23. Griffin K.J., Kirschner L.S., Matyakhina L., Stergiopoulos S.G., Robinson-White A., Lenherr S.M., Weinberg F.D., Claflin E.S., Batista D., Bourdeau I., Voutetakis A., Sandrini F., Meoli E.M., Bauer A.J., Cho-Chung Y.S., Bornstein S.R., Carney J.A., Stratakis C.A. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions. J. Med. Genet. 2004, 41:923-931.
24. Hinks G.L., Brown P., Field M., Poat J.A., Hughes J. The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze. Eur. J. Pharmacol. 1996, 312:153-161.
25. Howe D.G., Wiley J.C., Mcknight G.S. Molecular and behavioral effects of a null mutation in all PKA C beta isoforms. Mol. Cell Neurosci. 2002, 20:515-524.
26. Huang Y.Y., Kandel E.R., Varshavsky L., Brandon E.P., Qi M., Idzerda R.L., Mcknight G.S., Bourtchouladze R. A genetic test of the effects of mutations in PKA on mossy fiber LTP and its relation to spatial and contextual learning. Cell 1995, 83:1211-1222.
27. Impey S., Mccorkle S.R., Cha-Molstad H., Dwyer J.M., Yochum G.S., Boss J.M., Mcweeney S., Dunn J.J., Mandel G., Goodman R.H. Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 2004, 119:1041-1054.
28. Kim K.S., Lee K.W., Baek I.S., Lim C.M., Krishnan V., Lee J.K., Nestler E.J., Han P.L. Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior. J. Neurochem. 2008, 107:105-115.
29. Kirschner L.S., Kusewitt D.F., Matyakhina L., Towns W.H., Carney J.A., Westphal H., Stratakis C.A. A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues. Cancer Res. 2005, 65:4506-4514.
30. Kirschner L.S., Yin Z., Jones G.N., Mahoney E. Mouse models of altered protein kinase A signaling. Endocr. Relat. Cancer 2009, 16:773-793.
31. Konradi C., Cole R.L., Heckers S., Hyman S.E. Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J. Neurosci. 1994, 14:5623-5634.
32. Lapiz-Bluhm M.D., Bondi C.O., Doyen J., Rodriguez G.A., Bedard-Arana T., Morilak D.A. Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats. J. Neuroendocrinol. 2008, 20:1115-1137.
33. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl.) 1987, 92:180-185.
34. Malmberg A.B., Brandon E.P., Idzerda R.L., Liu H., Mcknight G.S., Basbaum A.I. Diminished inflammation and nociceptive pain with preservation of neuropathic pain in mice with a targeted mutation of the type I regulatory subunit of cAMP-dependent protein kinase. J. Neurosci. 1997, 17:7462-7470.
35. Mcnaughton N., Corr P.J. A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neurosci. Biobehav. Rev. 2004, 28:285-305.
36. Mcnish K.A., Gewirtz J.C., Davis M. Evidence of contextual fear after lesions of the hippocampus: a disruption of freezing but not fear-potentiated startle. J. Neurosci. 1997, 17:9353-9360.
37. Nesterova M., Bossis I., Wen F., Horvath A., Matyakhina L., Stratakis C.A. An immortalized human cell line bearing a PRKAR1A-inactivating mutation: effects of overexpression of the wild-type Allele and other protein kinase A subunits. J. Clin. Endocrinol. Metab. 2008, 93:565-571.
38. Nesterova M.V., Sashchenko L.P., Vasiliev V.Y., Severin E.S. A cyclic adenosine 3',5'-monophosphate-dependent histone kinase from pig brain. Purification and some properties of the enzyme. Biochim. Biophys. Acta 1975, 377:271-281.
39. Njung'e K., Handley S.L. Evaluation of marble-burying behavior as a model of anxiety. Pharmacol. Biochem. Behav. 1991, 38:63-67.
40. Palkovits M. Punch sampling biopsy technique. Methods Enzymol. 1983, 103:368-376.
41. Paxinos G., Franklin K.B. The Mouse Brain in Stereotaxic Coordinates 2001, Academic, San Diego, CA, London.
42. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 1985, 14:149-167.
43. Planas J.V., Cummings D.E., Idzerda R.L., Mcknight G.S. Mutation of the RIIbeta subunit of protein kinase A differentially affects lipolysis but not gene induction in white adipose tissue. J. Biol. Chem. 1999, 274:36281-36287.
44. Qi M., Zhuo M., Skalhegg B.S., Brandon E.P., Kandel E.R., Mcknight G.S., Idzerda R.L. Impaired hippocampal plasticity in mice lacking the Cbeta1 catalytic subunit of cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:1571-1576.
45. Rao Y., Fischer Q.S., Yang Y., McKnight G.S., LaRue A., Daw N.W. Reduced ocular dominance plasticity and long-term potentiation in the developing cortex of protein kinase A RII alpha mutant mice. Eur. J. Neurosci. 2004, 20:837-842.
46. Robinson-White A., Meoli E., Stergiopoulos S., Horvath A., Boikos S., Bossis I., Stratakis C.A. PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex. J. Clin. Endocrinol. Metab. 2006, 91:2380-2388.
47. Rogers R.J., Johnson N.J. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol. Biochem. Behav. 1995, 52:297-303.
48. Rubino T., Sala M., Vigano D., Braida D., Castiglioni C., Limonta V., Guidali C., Realini N., Parolaro D. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats. Neuropsychopharmacology 2007, 32:2036-2045.
49. Schiller D., Levy I., Niv Y., Ledoux J.E., Phelps E.A. From fear to safety and back: reversal of fear in the human brain. J. Neurosci. 2008, 28:11517-11525.
50. Schreyer S.A., Cummings D.E., Mcknight G.S., Leboeuf R.C. Mutation of the RIIbeta subunit of protein kinase A prevents diet-induced insulin resistance and dyslipidemia in mice. Diabetes 2001, 50:2555-2562.
51. Tasken K., Andersson K.B., Skalhegg B.S., Tasken K.A., Hansson V., Jahnsen T., Blomhoff H.K. Reciprocal regulation of mRNA and protein for subunits of cAMP-dependent protein kinase (RI alpha and C alpha) by cAMP in a neoplastic B cell line (Reh). J. Biol. Chem. 1993, 268:23483-23489.
52. Treit D., Pinel J.P., Fibiger H.C. Conditioned defensive burying: a new paradigm for the study of anxiolytic agents. Pharmacol. Biochem. Behav. 1981, 15:619-626.
53. Tsang K.M., Starost M.F., Nesterova M., Boikos S.A., Watkins T., Almeida M.Q., Harran M., Li A., Collins M.T., Cheadle C., Mertz E.L., Leikin S., Kirschner L.S., Robey P., Stratakis C.A. Alternate protein kinase A activity identifies a unique population of stromal cells in adult bone. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:8683-8688.
54. Weiser M.J., Wu T.J., Handa R.J. Estrogen receptor-beta agonist diarylpropionitrile: biological activities of R- and S-enantiomers on behavior and hormonal response to stress. Endocrinology 2009, 150:1817-1825.
55. Wood S.J., Toth M. Molecular pathways of anxiety revealed by knockout mice. Mol. Neurobiol. 2001, 23:101-119.
56. Yin H.S., Cheng P.R., Chen C.S. Differential alterations in the relations among GABAergic, catecholaminergic and calcium binding protein expression in the olfactory bulb of amphetamine-administered mouse. Neurotoxicology 2009, 30:103-113.
57. Zhang H.T., Huang Y., Masood A., Stolinski L.R., Li Y., Zhang L., Dlaboga D., Jin S.L., Conti M., Ódonnell J.M. Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). Neuropsychopharmacology 2008, 33:1611-1623.
58. Zhang X., Odom D.T., Koo S.H., Conkright M.D., Canettieri G., Best J., Chen H., Jenner R., Herbolsheimer E., Jacobsen E., Kadam S., Ecker J.R., Emerson B., Hogenesch J.B., Unterman T., Young R.A., Montminy M. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:4459-4464.